Abstract
Intrathecal baclofen is an expanding accepted treatment for children with cerebral palsy and other causes of spasticity and dystonia. The aims of this review are therefore to (1) delineate the clinical benefits of intrathecal baclofen therapy in pediatric spasticity and dystonia and (2) increase awareness of the potential complications and emergency management measures of intrathecal baclofen therapy. A current literature review demonstrates the benefits and complications of this minimally invasive device. Practical guides for recognizing acute conditions and management recommendations are included. Intrathecal baclofen is increasingly being used to help individuals attain realistic functional goals. Therefore, families and health care professionals should be aware of potential complications, symptoms, and emergency management.
| Original language | English |
|---|---|
| Pages (from-to) | 734-741 |
| Number of pages | 8 |
| Journal | Journal of Child Neurology |
| Volume | 33 |
| Issue number | 11 |
| DOIs | |
| State | Published - 1 Oct 2018 |
| Externally published | Yes |
Keywords
- cerebral palsy
- dystonia
- intrathecal baclofen
- overdose
- spasticity
- withdrawal
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Clinical Neurology